FORA Capital’s Veracyte VCYT Stock Holding History

FORA Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,636	Closed	-$206K	–	680
2025 Q2	$206K	Buy	+7,636	New	+$221K	0.02%	450
2021 Q1	–	Sell	-4,415	Closed	-$216K	–	1124
2020 Q4	$216K	Buy	4,415 +3,440	+353%	+$159K	0.03%	503
2020 Q3	$32K	Buy	+975	New	+$31K	0.02%	515
2020 Q2	–	Sell	-2,535	Closed	-$62K	–	1335
2020 Q1	$62K	Buy	+2,535	New	+$63.8K	0.01%	719

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's VCYT Position: Q3 2025 in Review

FORA Capital sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 7,636 shares — an estimated $206K sold.

FORA Capital first reported a position in VCYT in Q1 2020 and held it in 4 quarters. The position peaked at $216K in Q4 2020. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

FORA Capital reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
FORA Capital sold 7,636 Veracyte shares in Q3 2025, an estimated $206K.
FORA Capital first reported a position in Veracyte in Q1 2020 and held it in 4 quarters.
FORA Capital's Veracyte position peaked at $216K in Q4 2020.
298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.